Company Overview

Update
Founded:
May, 2006
Headquarters:
York
Funding:
$1.30M
Categories:
Health Care

Tissue Regenix commercializes innovative technologies in regenerative medicine.

Description

Update

Tissue Regenix was founded in May 2006, to commercialise innovative technologies in regenerative medicine. The underpinning science was developed over the last decade in the world-leading Institute for Medical and Biological Engineering at the University of Leeds by Professors John Fisher and Eileen Ingham. The research has received in excess of £4 million grant funding to date from UK research councils (EPSRC, BBSRC) and the Children's Heart Surgery Fund.

Funding Rounds (1) - $1.30M

Update

Investors (2)

Update
  • C0f2c3d673a73fc320b222447ebc0445

    White Rose Technology Seedcorn Fund

    The White Rose Technology Seedcorn Fund is an early stage seedcorn fund, which invests in exciting..
  • 0239a5b4576403656e07cb81efeb9c78

    IP Group Plc

    IP Group's core business is the creation of value for its shareholders and partners through..

Offices/Locations (1)

Update
  • Office

    The Biocentre

    Innovation Way, Heslington

    York, YO10 5NY

    GBR

Images (1)

Update
  • 8f55a201ebcebdbf9d00a89fb7174dc3